Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 109

    1.

    Answering the endocrine test questions.

    Schmidt CW.

    Environ Health Perspect. 1999 Sep;107(9):A458-60.PMID: 10464085 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Uncertainties for endocrine disrupters: our view on progress.

    Daston GP, Cook JC, Kavlock RJ.

    Toxicol Sci. 2003 Aug;74(2):245-52. Epub 2003 May 2. Review.PMID: 12730617 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Evaluation of Tier I screening approaches for detecting endocrine-active compounds (EACs).

    O'Connor JC, Cook JC, Marty MS, Davis LG, Kaplan AM, Carney EW.

    Crit Rev Toxicol. 2002;32(6):521-49. Review.PMID: 12487364 [PubMed - indexed for MEDLINE]Related articles

    4.

    In vitro models in endocrine disruptor screening.

    Charles GD.

    ILAR J. 2004;45(4):494-501. Review.PMID: 15454688 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Use of the laboratory rat as a model in endocrine disruptor screening and testing.

    Gray LE Jr, Wilson V, Noriega N, Lambright C, Furr J, Stoker TE, Laws SC, Goldman J, Cooper RL, Foster PM.

    ILAR J. 2004;45(4):425-37. Review.PMID: 15454681 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Tiered screening and testing strategy for xenoestrogens and antiandrogens.

    Gray LE Jr.

    Toxicol Lett. 1998 Dec 28;102-103:677-80.PMID: 10022334 [PubMed - indexed for MEDLINE]Related articles

    9.

    Are all EDC effects mediated via steroid hormone receptors?

    Fisher JS.

    Toxicology. 2004 Dec 1;205(1-2):33-41. Review.PMID: 15458788 [PubMed - indexed for MEDLINE]Related articles

    10.

    OECD test strategies and methods for endocrine disruptors.

    Gelbke HP, Kayser M, Poole A.

    Toxicology. 2004 Dec 1;205(1-2):17-25. Review.PMID: 15458786 [PubMed - indexed for MEDLINE]Related articles

    11.

    Xenoendocrine disrupters-tiered screening and testing: filling key data gaps.

    Gray LE Jr, Ostby J, Wilson V, Lambright C, Bobseine K, Hartig P, Hotchkiss A, Wolf C, Furr J, Price M, Parks L, Cooper RL, Stoker TE, Laws SC, Degitz SJ, Jensen KM, Kahl MD, Korte JJ, Makynen EA, Tietge JE, Ankley GT.

    Toxicology. 2002 Dec 27;181-182:371-82. Review.PMID: 12505339 [PubMed - indexed for MEDLINE]Related articles

    12.

    Ecological risk assessment of endocrine disruptors.

    Hutchinson TH, Brown R, Brugger KE, Campbell PM, Holt M, Länge R, McCahon P, Tattersfield LJ, van Egmond R.

    Environ Health Perspect. 2000 Nov;108(11):1007-14. Review.PMID: 11102288 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Endocrine disruption comes into regulatory focus.

    Baltz D.

    New Solut. 1999;9(1):29-35.PMID: 17208914 [PubMed]Related articles

    14.

    Endocrine disrupting chemicals research program of the U.S. Environmental Protection Agency: summary of a peer-review report.

    Harding AK, Daston GP, Boyd GR, Lucier GW, Safe SH, Stewart J, Tillitt DE, Van Der Kraak G.

    Environ Health Perspect. 2006 Aug;114(8):1276-82.PMID: 16882539 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Factors considered in using birds for evaluating endocrine-disrupting chemicals.

    Touart LW.

    ILAR J. 2004;45(4):462-8. Review.PMID: 15454685 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Lack of binding to isolated estrogen or androgen receptors, and inactivity in the immature rat uterotrophic assay, of the ultraviolet sunscreen filters Tinosorb M-active and Tinosorb S.

    Ashby J, Tinwell H, Plautz J, Twomey K, Lefevre PA.

    Regul Toxicol Pharmacol. 2001 Dec;34(3):287-91.PMID: 11754532 [PubMed - indexed for MEDLINE]Related articles

    17.

    Nature of the binding interaction for 50 structurally diverse chemicals with rat estrogen receptors.

    Laws SC, Yavanhxay S, Cooper RL, Eldridge JC.

    Toxicol Sci. 2006 Nov;94(1):46-56. Epub 2006 Aug 29.PMID: 16940337 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Overview of endocrine disruptor research activity in the United States.

    Kavlock RJ.

    Chemosphere. 1999 Oct;39(8):1227-36. Review.PMID: 10467717 [PubMed - indexed for MEDLINE]Related articles

    20.

    Use and role of invertebrate models in endocrine disruptor research and testing.

    deFur PL.

    ILAR J. 2004;45(4):484-93. Review.PMID: 15454687 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data